Creation of a Registry of Pediatric Respiratory Samples and Plasma/Sera to Define Viral Profiles and SARS-CoV2 Seroprevalence in Mississippi Children During the Global SARS-CoV2 (COVID19) Pandemic

About this Study

SARS-CoV2 is a novel coronavirus causing a pandemic and which has recently been spreading/diagnosed in MS with dramatically increasing frequency. There is limited data regarding co-infection with other respiratory viruses in children and increasing data supports SARS-CoV2-infected children are in fact, asymptomatic or pauci-symptomatic.  Children may present with non-specific symptoms that are attributed to other viruses. Understanding the presence of other viruses and the seroprevalence of antibodies to SARS-CoV2 and other coronaviruses at this time will allow clearer classification of disease within MS both prior to and during the first anticipated peak of SARS-CoV2.

Our goal is to create a registry of specimens for the main objective of this study, which is to understand better the viral co-infection profiles and SARS-CoV2 antibody profiles in asymptomatic and/or pauci-symptomatic children in various health care settings over time in MS.



Sponsor Protocol ID:N/A
IRB Number:2020-0099
Actively Enrolling
Observational
Observational/Not Applicable
June 08, 2020
Eligibility Criteria
18 years old
Both Male and Female
No
Yes
No

Inclusion Criteria

Age

Residual samples of serum or plasma available with at least 250 uL in volume.

Exclusion Criteria

None by age

Serum or plasma available without at least 250 uL in volume.

Categories Click category to view its trials.
COVID-19 (Coronavirus)
Participating Locations
University Hospital
Contact Information
Contact Name: Charlotte Hobbs
Phone Number: 601-984-5206
Email: chobbs@umc.edu
Principal Investigator:Hobbs, Charlotte V, M.D.
How to participate in our Clinical Trials